menu
    • menu

    Company profile for LivaNova

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LivaNova is a global medical technology company built on decades of experience and a relentless commitment to improve the lives of patients around the world. As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to helping create meaningful products and therapies that transform lives each and every day. LivaNova is also dedicated to the highest standards, and we operate at the topmost level of...
    LivaNova is a global medical technology company built on decades of experience and a relentless commitment to improve the lives of patients around the world. As a worldwide leader in cardiovascular and neuromodulation solutions, we are dedicated to helping create meaningful products and therapies that transform lives each and every day. LivaNova is also dedicated to the highest standards, and we operate at the topmost level of business ethics and compliance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LivaNovaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    20, Eastbourne Terrace, London, W2 6LG
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.livanova.com/en-us
    Linkedin
    Linkedin
    https://www.linkedin.com/company/livanova/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves LivaNova's Aura6000 for Moderate-to-Severe OSA
    FDA Approves LivaNova's Aura6000 for Moderate-to-Severe OSA

    19 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260319676324/en/LivaNova-Receives-U.S.-Food-and-Drug-Administration-Premarket-Approval-for-aura6000-System-to-treat-Moderate-to-Severe-Obstructive-Sleep-Apnea

    BUSSINESSWIRE
    19 Mar 2026
    Share Share
    Livanova Unveils 2025 Results, Provides 2026 Guidance
    Livanova Unveils 2025 Results, Provides 2026 Guidance

    25 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260225178019/en/LivaNova-Reports-Fourth-Quarter-and-Full-Year-2025-Results-Issues-2026-Guidance

    BUSINESSWIRE
    25 Feb 2026
    Share Share
    Livanova To Announce Fourth-Quarter And Full-Year 2025 Results
    Livanova To Announce Fourth-Quarter And Full-Year 2025 Results

    20 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260120610612/en/LivaNova-to-Announce-Fourth-Quarter-and-Full-Year-2025-Results

    BUSINESSWIRE
    20 Jan 2026
    Share Share
    Livanova To Present At J.P. Morgan Health Conf In January
    Livanova To Present At J.P. Morgan Health Conf In January

    23 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251223148352/en/LivaNova-to-Present-at-J.P.-Morgan-Healthcare-Conference-in-January

    BUSINESSWIRE
    23 Dec 2025
    Share Share
    LivaNova Showcases CORE-VNS Study Data At AES 2025 Meeting
    LivaNova Showcases CORE-VNS Study Data At AES 2025 Meeting

    03 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251203929955/en/LivaNova-to-Highlight-Real-World-Evidence-from-CORE-VNS-Study-and-New-Health-Economics-Analyses-at-American-Epilepsy-Society-2025-Annual-Meeting

    BUSINESSWIRE
    03 Dec 2025
    Share Share
    Livanova Names Lucile Blaise Global Commercialization Head
    Livanova Names Lucile Blaise Global Commercialization Head

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202334791/en/LivaNova-Appoints-Lucile-Blaise-as-Global-Head-of-Commercialization-Obstructive-Sleep-Apnea

    BUSINESSWIRE
    02 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search